Cell Line Development

A robust cell line is the cornerstone of successful biologics manufacturing. High-producing, genetically stable cell lines not only determine product yield and quality but also significantly influence process robustness, manufacturing consistency, and long-term commercial success. At Protheragen, our cell line development platform integrates advanced vector engineering, optimized host cell systems, high-throughput clone screening, and comprehensive stability evaluation to rapidly generate high-performing production cell lines. Designed to seamlessly integrate with upstream process development and GMP manufacturing, our platform helps accelerate development timelines while reducing manufacturing risks.

Overview of Cell Line Development

Cell line development is the process of establishing genetically stable mammalian cell lines capable of consistently producing recombinant therapeutic proteins with the desired quality attributes and productivity. Unlike transient expression systems that support rapid protein production for early-stage research, stable cell line development integrates the target gene into the host cell genome, allowing long-term, reproducible protein expression suitable for process development, clinical manufacturing, and commercial production.

Modern cell line development combines advanced molecular biology, automated single-cell cloning technologies, high-throughput clone screening, and comprehensive cell characterization to identify production clones with optimal productivity, stability, and product quality. This systematic approach minimizes downstream manufacturing risks while providing a reliable foundation for scalable biologics production.

Fig.1 Illustration of a typical process to develop a mammalian cell line for recombinant protein manufacturing (Lai, T., et al., 2013)

Our Services

Our integrated cell line development platform covers every critical stage from vector engineering to clone selection and characterization. By combining advanced molecular biology techniques with rigorous screening strategies, we establish stable, high-producing cell lines that provide a reliable foundation for downstream process development and biomanufacturing.

Key Advantages

• High Productivity

Our optimized expression platform enables the rapid identification of high-producing clones suitable for process development and large-scale manufacturing.

• Excellent Genetic Stability

Selected production clones undergo rigorous stability studies to ensure consistent expression and product quality across extended cell passages.

• Superior Product Quality

Our clone selection strategy considers not only productivity but also critical quality attributes (CQAs), including glycosylation patterns, aggregation, and molecular integrity.

• Scalable Development

Cell lines are developed using suspension culture platforms compatible with process scale-up from laboratory studies to GMP manufacturing.

• Regulatory-Ready Documentation

Comprehensive project documentation is generated throughout cell line development to support downstream CMC activities and regulatory submissions, facilitating a smooth transition toward IND-enabling studies and GMP manufacturing.

Rapid Stable Cell Line Generation Process

The proprietary Cell Line Development platform enables the generation of stable, high-producing monoclonal cell lines in as little as 3 months, significantly reducing development timelines compared with conventional CLD workflows that typically require 5–6 months.

Applications

Our Cell Line Development services support a broad range of recombinant biologics, including:

Why Choose Us

• Optimized Mammalian Expression Platform
  Robust CHO-based expression systems deliver stable, high-yield recombinant protein production.
• Comprehensive Clone Screening
  High-throughput screening enables rapid identification of clones with optimal productivity and product quality.
• Reliable Long-Term Stability
  Rigorous genetic and expression stability studies support consistent manufacturing performance.
• Integrated Development Strategy
  Cell line development is fully aligned with downstream process development, analytical characterization, and GMP manufacturing.
• Experienced Scientific Team
  Our multidisciplinary scientists combine expertise in molecular biology, cell engineering, process development, and analytical sciences to accelerate biologics development.

A high-quality production cell line is the starting point for efficient and reliable biologics manufacturing. At Protheragen, we combine advanced cell line engineering, comprehensive clone evaluation, and scalable development strategies to generate stable, high-producing cell lines tailored to your project needs. Our integrated Cell Line Development services provide a seamless transition into process development and GMP manufacturing, helping you accelerate timelines, reduce development risks, and move confidently toward clinical and commercial success. Contact us to discuss your project and discover how our integrated Cell Line Development services can support every stage of your biologics development journey.